|
Officers
Board Members
Henry A. McKinnell, Jr., Ph.D., Chairman of the BoardHank McKinnell retired as Chairman and CEO of Pfizer Inc, the world’s largest research-based pharmaceutical company, in 2006. Hank joined Pfizer in 1971 in Tokyo. Over the years, he held positions of increasing responsibility around the world, including service as president of Pfizer Asia, based in Hong Kong. He also served as Pfizer’s country manager-Iran/Afghanistan. In 1984 Hank relocated to New York, where he served as vice president-strategic planning, chief financial officer, president-Pfizer medical device group, president-Pfizer pharmaceuticals group, president and chief operating officer, president and chief executive officer from January 2001 to May 2001, and as chairman and chief executive officer, from May 2001 to August 2006, and chairman to December, 2006. Hank McKinnell is a member of the Boards of Directors of Moody’s Corporation, and ExxonMobil Corporation. Hank is a member of the Academic Alliance and chairman of the Academic Alliance Foundation, which supports infectious diseases prevention, care and treatment in Sub-Sahara Africa. He is also chairman of the Connecticut Science Center. Hank is Chairman Emeritus of the Business Roundtable, an association of 170 CEO’s of America’s largest companies, the Pharmaceutical Research Manufacturers Association, the Food and Drug Law Institute, and the Medical Device Manufacturers Association. Hank also served as vice chairman of the World Economic Forum and as a member of the WEF Foundation Board of Trustees. Hank served on the President’s Advisory Council on HIV/AIDS. He is a director of the Medal of Honor Foundation, the Royal Shakespeare Company of America, the Japan Society, and a member of the Stanford University Graduate School of Business Advisory Council. He is a member of the Boards of Trustees of the New York City Public Library. Hank holds a Bachelor's Degree in business from the University of British Columbia, and M.B.A. and Ph.D. degrees from the Stanford University Graduate School of Business. Recent honors include the Grand Cordon of the Order of the Rising Sun, Japan’s highest award to other than members of the Imperial Family and heads of state; the Islamic Republic of Pakistan’s Sitara-i-Eisaar award, Pakistan’s highest award for humanitarian relief; the Presidential Distinguished Service Award for contributions to health services in Uganda; the United Nations Association of the United States of America’s Global Leadership Award; the Woodrow Wilson Institute Corporate Service Award, Columbia University’s Teachers College Cleveland E. Dodge Medal for Distinguished Service to Education; Stanford University’s Graduate School of Business Arbuckle Award and Excellence in Leadership Award; and an honorary doctorate in engineering from Polytechnic University. Gary M. CohenAs Executive Vice President of BD, Gary Cohen dedicates a significant amount of his time addressing developing world health issues. He has made this personal commitment because he believes that the Company’s capabilities and experience in medical technology can help to save and improve countless lives around the world. Gary began his career with BD in 1983 as a marketing research analyst. He became president of the company’s global injection business in 1994. In 1997 he was also appointed president of BD for Europe, the Middle East and Africa. He held the position of president, BD Medical, one of three business segments of BD, from 1999 to 2006. He was appointed to his current position in June 2006. He earned a BA at Rutgers College and a MBA at the Rutgers Graduate School of Business, and he presently serves on the University’s Board of Trustees. He is an executive officer of BD and a member of the Board of Directors of the Perrigo Company. He is also a Board Director of the US Fund for UNICEF and the CDC Foundation. He is also a non-permanent member of the private sector delegation to the Global Fund to Fight HIV/AIDS, TB and Malaria. Susan Desmond-Hellmann, M.D., M.P.H.Susan Desmond-Hellmann is the President of Product Development and Chief Medical Officer at Genentech, Inc. As President, Hellmann is responsible for Genentech's Medical Affairs, Regulatory Affairs, Product Portfolio Management, Business Development, Development Sciences, Compliance and Quality. She is also a member of Genentech's Executive Committee. Prior to joining Genentech, Hellmann was associate director of clinical cancer research at Bristol-Myers Squibb Pharmaceutical Research Institute and the Project Team Leader for Taxol. Hellmann is currently adjunct associate professor, Epidemiology and Biostatistics at the University of California, San Francisco; she was formerly Assistant Professor, Hematology-Oncology, also at UCSF. She has won many honors and awards since 1980 for her work in Oncology and AIDS research. During her nine years of training in internal medicine and oncology, Dr. Hellmann spent two years as visiting faculty at the Uganda Cancer Institute and Mulago Hospital, studying AIDS and cancer. Joseph M. Feczko, M.D.Joseph Feczko is currently Senior Vice President and Chief Medical Officer of Pfizer Inc, with global responsibility for all aspects of the company’s medical affairs. Following a medical career specializing in internal medicine and infectious diseases, he worked in the UK for Pfizer and Glaxo, where his roles included Medical Director and Director of Global Regulatory Operations. He is a Board member of the advisory Technology Strategy Board, the National Foundation for Infectious Diseases, the International Trachoma Initiative, The New York Academy of Medicine, the Academic Alliance Foundation Board, as well as a member of the Pharmaceutical Drug Forum of the Institute of Medicine, and was recently named Vice Chair of the Advisory Board University of Miami Center for Aging Research. Warner C. Greene, M.D., Ph.D.Warner C. Greene, M.D., Ph.D., is founding director and senior investigator of the Gladstone Institute of Virology and Immunology, professor of medicine, microbiology and immunology at the University of California, San Francisco and President of Accordia Global Health Foundation. Under his direction, the Gladstone Institute has established an international reputation for excellence in the study of HIV and AIDS. Dr. Greene also serves as co-director of the federally funded UCSF-Gladstone Center for AIDS Research. The author of more than 280 scientific papers, Dr. Greene has been honored by outstanding investigator awards from the American Federation for Clinical Research and the American College of Rheumatology and has been recognized by the Institute for Scientific Information as one of the 100 most-cited scientists in the world. King K. Holmes, M.D., Ph.D.Dr. Holmes, Professor of Medicine, directs the University of Washington (UW) Center for AIDS and STDs, which involves 245 UW-affiliated faculty and research scientists and 85 pre- and post-doctoral trainees; and heads the Infectious Diseases Section at Harborview Medical Center in Seattle, Washington. He is the principle investigator for two NIH Center grants (the UW Center for AIDS Research and the UW STI Cooperative Research Center), and for two UW AIDS/STD research training programs. He has participated in research on STIs in developing countries for 40 years, and in research, training, and technical assistance on HIV/AIDS and other STIs in Africa, Latin America, SE Asia, and the Western Pacific for over 20 years. He has participated in the design and conduct of 6 randomized controlled trials of STI prevention, the most recent a trial of expedited treatment of sex partners of patients with gonococcal or chlamydial infection, which demonstrated a 75% decrease in persistent or recurrent gonococcal infection in the index patient (M. Golden, NEJM, 2005). He currently leads a randomized trial of topical microbicide use by men in fishing communities on Lake Victoria for prevention of STI/HIV acquisition, and a Welcome Trust/NIH-funded 20-city randomized trial of STD/HIV prevention in Peru. He has authored over 470 peer-reviewed publications and edited 30 journal supplements and books. He serves as PI of the UW/UCSF International Training & Education Center on HIV (I-TECH), funded by the US government to provide training and support for HIV/STI management, care, and prevention in 13 countries. He has trained and/or mentored over 100 scientists involved in HIV/STI research and care in the US and other countries throughout the world, several of whom (e.g., Larry Corey, Judy Wasserheit, Sharon Hillier) are active in the clinical trials network leadership. Donald A. Holzworth, M.S.Donald A. Holzworth is a Senior Vice President and Director of the Global Health Sector of SRA International, Inc. He was the former Founder, Chairman, and Chief Executive Officer of Constella Group, a leading global provider of health consulting services dedicated to enhancing human health around the world, every day. On August 9, 2007, Holzworth completed the sale of Constella to SRA. Holzworth guided Constella's revenue growth to more than $200 million, increased the company's number of employees from to more than 1,500, and the scope of the company’s operations to 61 countries. In 2003 and again in 2007, the North Carolina Council for Entrepreneurial Development recognized Constella with its prestigious Entrepreneurial Excellence Award. Ernst & Young named Holzworth as a 2005 Carolinas Entrepreneur of the Year®. Prior to Constella, Mr. Holzworth spent 9 years as a senior executive with another consulting firm, leading that company’s life sciences business and growth from $6 million to $70 million in revenue before its sale in 1990. In 2002, Holzworth was a co-founder and served as the inaugural CEO of Expression Analysis, Inc., a start-up genetic research company spun out of Duke University Medical Center. He now serves as the company's Chairman of the Board. Holzworth also serves on the board of directors for the Campbell Alliance Group and the Academic Alliance Foundation. He is a member of the University of North Carolina at Chapel Hill School of Public Health's Advisory Board, the University of North Carolina at Chapel Hill’s Board of Visitors, and the advisory board of Southern Capitol Ventures. Robert MallettRobert L. Mallett is Senior Vice President, Global Stakeholder Alliances, Philanthropy & Corporate Citizenship at Pfizer Inc and President of the Pfizer Foundation. He has direct supervision of Pfizer’s global policy and economic research group, philanthropy and corporate giving department, multilateral institutions and alliance development unit, as well as serving as the coordinator for the company’s intellectual property policy positioning. Prior to joining Pfizer in April 2001, Mr. Mallett served as Deputy Secretary of the U.S. Department of Commerce where he oversaw the administrative and policy operations of a number of key federal agencies. By appointment of the President, he served on the Board of the Overseas Private Investment Corporation and was a member of the 3-member Federal Steel Loan Guaranty Board. Prior to his federal executive service, Mr. Mallett was a shareholder and associate attorney of major Washington, D.C. based law firms. He has also served as City Administrator and Deputy Mayor for the District of Columbia and Legal Counsel to former United States Senator Lloyd Bentsen. He has been an adjunct professor at Georgetown University’s Law Center, and was a Visiting Professor at Harvard University’s John F. Kennedy School of Government. He served as a law clerk to the Honorable John R. Brown of the United States Court of Appeals for the Fifth Circuit. Mr. Mallett is a member of the Council on Foreign Relations, an elected Fellow of the National Academy of Public Administrators, Chairman of the U.S.-South Africa Business Council, a member of the Board of Directors of the International Trachoma Initiative (chair-elect), Appleseed Foundation (chair-elect), Medical Education for South African Blacks, and a local hospital in New York’s historic Harlem community. He is the former Chairman and a member of the Board of Governors of Wesley Theological Seminary. He resides in New York City. Fred PortFred retired as a Director of Callaway Golf and President of Callaway Golf International. He served in a variety of Board and senior management positions with several companies over 35 years with emphasis on strategic change, global operations/partnerships, acquisitions and estructure. In addition, he dedicated substantial effort to community activities -- most recently recognized as Director of the Year for Court Appointed Special Advocates (CASA), selected for his 20 years of service from more than 900 programs throughout the United States. An honors graduate of the Anderson School at UCLA (MBA), he is a frequent speaker and mentor for those confronting cancer (he is a survivor). Nelson Sewankambo, M.D.Dr. Sewankambo, MBChB, MMED, MSc is Dean of Medicine at Makerere University in Kampala, Uganda, Co-Chair of the Academic Alliance and Principal Investigator (PI) of the Rakai Project. Dr. Sewankambo was among the first scientists to publish data on AIDS in Africa. He was instrumental in starting the AIDS Clinic at Mulago hospital. Dr. Sewankambo managed the Clinic until he became Associate Dean in mid '90s. He was founding Director of the Clinical Epidemiology Unit, and a co-PI on the Canadian IDRC-funded behavioral and qualitative research on AIDS Prevention. He is a member of the population-based studies working group of the African AIDS Vaccine Programme. Dr. Sewankambo has served on numerous local and international advisory boards including the Working Party on the Ethics of Clinical Research in Developing Countries of the Nuffield Council for Bioethics, the Global Research Ethics Forum of the NIH, the WHO African Advisory Committee on Health and Research Development (AACHRD), and the Board of Directors of the International Clinical Epidemiology Network (INCLEN). Carol Spahn Carol Spahn is Executive Director of Accordia Global Health Foundation and is responsible for implementing new strategies and forging new partnerships to expand the impact of healthcare capacity building efforts in Africa undertaken by the organization. Ms. Spahn previously served Accordia as its Director of Finance and Administration. Prior to joining Accordia Global Health Foundation, Ms. Spahn was Vice-President, Chief Financial Officer and Treasurer of Small Enterprise Assistance Funds, a non-profit private equity fund manager that invests in small and medium sized companies in developing countries. Ms. Spahn served in the U.S. Peace Corps as a Small Business Advisor in Romania shortly after the fall of communism and has held several positions with leading financial service institutions, including GE Capital and KPMG Peat Marwick. She holds an M.A. in International Development from the George Washington University Elliott School of International Affairs. Tommy G. ThompsonTommy G. Thompson, the former Health and Human Services Secretary and four-term Governor of Wisconsin, is Chairman of the Deloitte Center for Health Solutions and a partner at the law firm of Akin Gump Strauss Hauer & Feld. At Deloitte and Akin Gump, Secretary Thompson is building on his efforts as HHS Secretary and Governor to develop innovative solutions to the health care challenges facing American families, businesses, communities, states and the nation as a whole. These efforts focus on improving the use of information technology in hospitals, clinics and doctors offices; promoting healthier lifestyles; strengthening and modernizing Medicare and Medicaid; and expanding the use of medical diplomacy around the world. Secretary Thompson served as HHS Secretary from 2001 to 2005 and is one of the nation's leading advocates for the health and welfare of all Americans. Secretary Thompson has dedicated his professional life to public service and served as Governor of Wisconsin from 1987 to 2001. Secretary Thompson made state history when he was re-elected to office for a third term in 1994 and a fourth term in 1998. |
|
||||
|
About the Foundation
|
Our Mission
|
Infectious Diseases Institute
|
Special Initiatives
|
Donations & Support
|
Grant Information | Related Links |
Terms of Use | PRIVACY | |
| © 2004 - , Accordia Global Health Foundation | ||